Search





Search





Markets
/
Stocks
/
nasdaq-rvp
/

Retractable Technologies Inc

RVP

Add to Watchlist

0.640USD

-0.050-7.25%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

19.16MMarket Cap

LossP/E TTM



Retractable Technologies Inc

0.640

-0.050-7.25%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Retractable Technologies Inc

Currency: USD Updated: 2026-05-15

Key Insights

Retractable Technologies Inc's fundamentals are relatively stable, with low ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 149 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Retractable Technologies Inc's Score

Industry at a Glance

Industry Ranking

149 / 206

Overall Ranking

415 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Retractable Technologies Inc Highlights

StrengthsRisks

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Growing

The company is in a growing phase, with the latest annual income totaling USD 38.27M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 38.27M.

Fairly Valued

The company’s latest PE is -2.94, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 3.30M shares, increasing 15.99% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 447.01K shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Retractable Technologies Inc is 6.02, ranking 172 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 7.18M, representing a year-over-year decrease of 13.48%, while its net profit experienced a year-over-year decrease of 59.44%.

Score

Industry at a Glance

Previous score

6.02

Change



Financials

5.29

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

3.70

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.14

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.88

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.10

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Retractable Technologies Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Retractable Technologies Inc is 7.47, ranking 81 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.94, which is -568.96% below the recent high of 13.78 and -1219.63% above the recent low of -38.78.

Score

Industry at a Glance

Previous score

7.47

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 149/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

No earnings forecast score is currently available for Retractable Technologies Inc. The Healthcare Equipment & Supplies industry's average is 7.80.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Retractable Technologies Inc is 6.66, ranking 104 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.73 and the support level at 0.58, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.18

Change

-0.52

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.003

Buy

RSI(14)

42.818

Neutral

STOCH(KDJ)(9,3,3)

29.711

Sell

ATR(14)

0.045

High Vlolatility

CCI(14)

-28.907

Neutral

Williams %R

78.556

Sell

TRIX(12,20)

0.100

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.683

Sell

MA10

0.688

Sell

MA20

0.663

Sell

MA50

0.682

Sell

MA100

0.699

Sell

MA200

0.770

Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Retractable Technologies Inc is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 11.01%, representing a quarter-over-quarter increase of 34.16%. The largest institutional shareholder is James Simons, holding a total of 404.01K shares, representing 1.35% of shares outstanding, with 12.34% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Shaw (Thomas J)

16.33M

+0.08%

Larios Michele Mitchell

861.00K

Eversept Partners, LP

580.92K

+59.89%

Renaissance Technologies LLC

Star Investors

447.01K

+4.55%

BlackRock Institutional Trust Company, N.A.

241.12K

Geode Capital Management, L.L.C.

128.11K

Bridgeway Capital Management, LLC

88.54K

Laterza (Marco)

85.00K

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Retractable Technologies Inc is 2.69, ranking 146 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.27. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Retractable Technologies Inc’s latest ESG disclosure lags behind the Healthcare Equipment & Supplies industry average, suggesting potential exposures in governance structure, environmental management, or social responsibility that may amplify risk and warrant ongoing monitoring.